REMEDUS

Active

Private limited companyfounded 1995active for 30 yearsSatenrozen 19, 2550 Kontich, BelgiumKBO/BCE: BE 0456.716.679

From the official registers: KBO 29 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

REMEDUS has been active since 1995 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €463,351 and a net result of €736,403. Equity is shrinking by about 15% per year across the filed financial years. Its solvency ranks better than 16% of 783 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow Report Compare

REMEDUSActiveChecked score 91/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 21-12-1995 Normal situation
Legal form: Private limited company
Registered office: Satenrozen 19, 2550 Kontich
Activity: Nutrition and dietetics services NACE 86995and 2 others
Establishment unit: 2.074.564.041 2550 Kontich, since 05-01-1996
Financial year end: 31 December
Peppol: Reachable since 21-10-2026

Company details

Who decides

Board

Medeco NVDirector · since 01-10-2021
Julie SteytDirector · since 15-07-2024

Auditor: BV Baker Tilly Bedrijfsrevisoren

Shareholders

MEDECO100%annual accounts 2025

Board & ownership

How it is doing

91 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: 0.1%

Annual accounts 2025

Turnover: €16.7m; ▲ 6.2%
Profit: €736,403; ▲ 424%
Equity: €463,351; ▼ 12.1%
Total assets: €4.2m; ▼ 20.4%
Staff: 64.6 FTE; ▲ 6.3%

2025 accounts 24 days early

Filed on 07-07-2026at the National Bank

Financials

Why 91raises risk2 of the last 3 lateEquity €463,351 (10.9% of total assets)lowers riskSector: Human health activities (NACE 86)Size: turnover €16.7m, 64.6 FTE, total assets €4.2mShow the evidence

Checked score

Score 2025

91 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 35% of its sector peers (NACE 86, medium-sized)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Weak

Solvency 36+1

equity 10.9% of total assets

Liquidity 15-25

short-term debt 86.8% · cash 10.3%

Profitability 80+19

return on assets 17.3%

Bankruptcy probability, 12 months

0.1% Very low

0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (84 companies, NACE 86, medium-sized)

Last 24 months 11-2024: 0.6% 12-2024: 0.8%▲ +0.2 percentage points vs 11-2024 01-2025: 1.3%▲ +0.5 percentage points vs 12-2024highest value 02-2025: 0.2%▼ -1.1 percentage points vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.2%● unchanged vs 06-2025 08-2025: 0.3%▲ +0.1 percentage points vs 07-2025 09-2025: 0.4%▲ +0.1 percentage points vs 08-2025 10-2025: 0.5%▲ +0.1 percentage points vs 09-2025 11-2025: 0.5%● unchanged vs 10-2025 12-2025: 0.3%▼ -0.2 percentage points vs 11-2025 01-2026: 0.3%● unchanged vs 12-2025 02-2026: 0.3%● unchanged vs 01-2026 03-2026: 0.3%● unchanged vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.2%▼ -0.1 percentage points vs 06-2026 08-2026: 0.1%▼ -0.1 percentage points vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026lowest value

Credit of up to €40,000 on 30-day terms is acceptable

Liquidity insufficient (current ratio 0.87, compared with 0.9 in 2024, below 1; short-term debt: 86.8% and cash: 10.3% of total assets), and 89.1% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, medium-sized): better than 15% on solvency, 9% on liquidity, 75% on profitability and 40% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.

lowers riskraises riskneutral

Sector: Human health activities (NACE 86)

KBO

Size: turnover €16.7m, 64.6 FTE, total assets €4.2m

Companies of this size fail less often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

2 of the last 3 late

NBB · filings

Equity €463,351 (10.9% of total assets)

NBB · annual accounts

Weak solvency vs sector

Solvency (equity / total assets) is in the sector's weakest quartile: better than 16% of 783 sector peers (2025).

NBB · sector comparison

Position among 783 sector peers

Solvency

better than 16%

← weakest strongest →

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-07-2026, 24 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

24 days early

2024

105 days late

2023

155 days late

2022

301 days late

2021

19 days early

2021

40 days early

2020

114 days late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 85 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 13 November (4 of the last 5 filed years within 129 days of that day).

Companies Code · seven months

Where today falls in the filing period

01-11-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

Key points

Positive: Result rose in 2025from €140,636 to €736,403 ▲ 424% View
Positive: Among the best 6% on net resultsector median €70,518 · 777 companies €736,403 View
Positive: 8 profitable years in a rowprofit 2025: €736,403 8 years View

Documents

Key facts about REMEDUS

What is the company number of REMEDUS?: 0456.716.679. In Belgium the VAT number is the company number with BE in front: BE 0456.716.679.
Where is REMEDUS based?: The registered office is at Satenrozen 19, 2550 Kontich.Company details
What does REMEDUS do?: According to the KBO register, the main activity is nutrition and dietetics services (NACE 86995).
What is the legal form of REMEDUS?: Private limited company (BV).
When was REMEDUS founded?: On 21-12-1995.
Is REMEDUS still active?: Yes, REMEDUS is an active enterprise in the KBO register.
How many employees does REMEDUS have?: On average 64.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of REMEDUS?: €16.7m in financial year 2025, according to the filed annual accounts.
Is REMEDUS profitable?: In financial year 2025, REMEDUS made a profit of €736,403.
Where can I find the annual accounts of REMEDUS?: REMEDUS filed 29 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of REMEDUS due?: By 31-07-2027, for financial year 2026.Timeline